PHARMING GROUP NV (PHARM.AS) Stock Analyst Ratings

AMS:PHARM • NL0010391025

1.333 EUR
+0 (+0.3%)
Last: Feb 17, 2026, 02:19 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

89

ChartMill assigns a Buy % Consensus number of 89% to PHARM.AS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 2.19. This target is 64.52% above the current price.
  • PHARM.AS was analyzed by 14 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about PHARM.AS.
  • In the previous month the buy percentage consensus was at a similar level.
  • PHARM.AS was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
PHARM.AS Historical Analyst RatingsPHARM.AS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.331.822.042.192.73 - 36.38% 53.04% 64.52% 104.80%

Related screens

Find peers 30% below price target
PHARM.AS Current Analyst RatingPHARM.AS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades

PHARMING GROUP NV / PHARM.AS FAQ

What is the average price target for PHARMING GROUP NV (PHARM.AS) stock?

14 analysts have analysed PHARM.AS and the average price target is 2.19 EUR. This implies a price increase of 64.52% is expected in the next year compared to the current price of 1.333.


What is the consensus rating for PHARM stock?

The consensus rating for PHARMING GROUP NV (PHARM.AS) is 88.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed PHARMING GROUP NV (PHARM.AS)?

The number of analysts covering PHARMING GROUP NV (PHARM.AS) is 14.